You can buy or sell LPTX and other stocks, options, ETFs, and crypto commission-free!
Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company. Read More It invests in great science and targeted research will rapidly translate molecules into high impact therapeutics. The firm's pipeline is built upon identifying and developing translational-stage molecules in the areas of cell signaling and immuno-oncology. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMar 11
Four Tech Stocks Setting The Pace On Monday
CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / The success of the tech stock market is directly correlated to the operating assumption that tech companies are prepared to meet the rising challenges presently facing society.
PR NewswireMar 8
Leap Therapeutics to Present at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer
CAMBRIDGE, Mass., March 8, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Company will be presenting at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer, being held March 16-19, 2019 in Honolulu, HI. About the DKN-01 P204 clinical trial The P204 study is a Phase 2 basket study of DKN-01 as both a monotherapy and in combination with paclitaxel in patients with ...
-$0.57 per share
Expected Today, Pre-Market